docetaxel,vinorelbine,carboplatin,cisplatin,paclitaxel,ipilimumab,nivolumab,pemetrexed,osimertinib,gemcitabine,pembrolizumab,vinflunine,durvalumab
merck,pierre fabre,aura biosciences,novocure,astrazeneca,bms
['docetaxel']
#asco23 lunar: post-platinum ttfields with ici/docetaxel
1 ttfields + ici/docetaxel vs. ici/docetaxel
2 os 13 vs. 10 mos hr 0.74 (more benefit when combined w/ ici hr 0.63)
3 31% received prior ici ttfields synergistic w/ ici; 1st line try
more will be 
Hematology/Medical Oncology Fellow @RoswellPark
Thoracic Oncology Researcher
Future Asst Professor @UW & @FredHutch
Retweet ≠ endorsement
Views are my own